Early Detection develops non-invasive and accurate screening tests for an abnormal sugar molecule expressed only in cancer.
Early Detection has raised $25K in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Early Detection is headquartered in San Diego, United States.
Early Detection develops non-invasive and accurate screening tests for an abnormal sugar molecule expressed only in cancer.
Early Detection is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Early Detection — Funding & Investors." VCBacked, March 16, 2023, https://www.vcbacked.co/company/early-detection. Accessed August 14, 2026.
VCBacked. (2023). Early Detection — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/early-detection
{{cite web |title=Early Detection — Funding & Investors |url=https://www.vcbacked.co/company/early-detection |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated